127 related articles for article (PubMed ID: 32545165)
1. Understanding the Mechanism of Recognition of Gab2 by the N-SH2 Domain of SHP2.
Visconti L; Malagrinò F; Pagano L; Toto A
Life (Basel); 2020 Jun; 10(6):. PubMed ID: 32545165
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Folding and Binding of the N-Terminal SH2 Domain from SHP2.
Bonetti D; Troilo F; Toto A; Travaglini-Allocatelli C; Brunori M; Gianni S
J Phys Chem B; 2018 Dec; 122(49):11108-11114. PubMed ID: 30047735
[TBL] [Abstract][Full Text] [Related]
3. Determining folding and binding properties of the C-terminal SH2 domain of SHP2.
Nardella C; Malagrinò F; Pagano L; Rinaldo S; Gianni S; Toto A
Protein Sci; 2021 Dec; 30(12):2385-2395. PubMed ID: 34605082
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of Binding Induced Structural Plasticity in a SH2 Domain.
Visconti L; Toto A; Jarvis JA; Troilo F; Malagrinò F; De Simone A; Gianni S
Front Mol Biosci; 2020; 7():89. PubMed ID: 32528972
[TBL] [Abstract][Full Text] [Related]
5. An intramolecular energetic network regulates ligand recognition in a SH2 domain.
Nardella C; Pagano L; Pennacchietti V; Felice MD; Matteo SD; Diop A; Malagrinò F; Marcocci L; Pietrangeli P; Gianni S; Toto A
Protein Sci; 2023 Aug; 32(8):e4729. PubMed ID: 37468946
[TBL] [Abstract][Full Text] [Related]
6. Folding and Binding Kinetics of the Tandem of SH2 Domains from SHP2.
Pagano L; Pennacchietti V; Malagrinò F; Di Felice M; Toso J; Puglisi E; Gianni S; Toto A
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928272
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of an on-pathway intermediate and transition state in the folding of the N-terminal SH2 domain from SHP2.
Visconti L; Malagrinò F; Gianni S; Toto A
FEBS J; 2019 Dec; 286(23):4769-4777. PubMed ID: 31287606
[TBL] [Abstract][Full Text] [Related]
8. Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state.
Calligari P; Santucci V; Stella L; Bocchinfuso G
Comput Struct Biotechnol J; 2021; 19():6125-6139. PubMed ID: 34900129
[TBL] [Abstract][Full Text] [Related]
9. Understanding the mechanism of binding between Gab2 and the C terminal SH3 domain from Grb2.
Toto A; Bonetti D; De Simone A; Gianni S
Oncotarget; 2017 Oct; 8(47):82344-82351. PubMed ID: 29137268
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations.
Wang Q; Zhao WC; Fu XQ; Zheng QC
Front Chem; 2020; 8():597495. PubMed ID: 33330386
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the Molecular Basis of the Noonan Syndrome-Causing Mutation T42A of SHP2.
Toto A; Malagrinò F; Visconti L; Troilo F; Gianni S
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936901
[TBL] [Abstract][Full Text] [Related]
12. A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners.
Crouin C; Arnaud M; Gesbert F; Camonis J; Bertoglio J
FEBS Lett; 2001 Apr; 495(3):148-53. PubMed ID: 11334882
[TBL] [Abstract][Full Text] [Related]
13. Characterization of early and late transition states of the folding pathway of a SH2 domain.
Toto A; Malagrinò F; Nardella C; Pennacchietti V; Pagano L; Santorelli D; Diop A; Gianni S
Protein Sci; 2022 Jun; 31(6):e4332. PubMed ID: 35634781
[TBL] [Abstract][Full Text] [Related]
14. Molecular interactions of SHP1 and SHP2 in IL-3-signalling.
Wheadon H; Paling NR; Welham MJ
Cell Signal; 2002 Mar; 14(3):219-29. PubMed ID: 11812650
[TBL] [Abstract][Full Text] [Related]
15. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
16. The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain.
van Vlimmeren AE; Voleti R; Chartier CA; Jiang Z; Karandur D; Humphries PA; Lo WL; Shah NH
bioRxiv; 2024 Apr; ():. PubMed ID: 37502916
[TBL] [Abstract][Full Text] [Related]
17. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.
Isakov N; Wange RL; Burgess WH; Watts JD; Aebersold R; Samelson LE
J Exp Med; 1995 Jan; 181(1):375-80. PubMed ID: 7528772
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R
Cancer Res; 2007 May; 67(9):4278-86. PubMed ID: 17483340
[TBL] [Abstract][Full Text] [Related]
19. Experiment-guided molecular simulations define a heterogeneous structural ensemble for the
Marasco M; Kirkpatrick J; Carlomagno T; Hub JS; Anselmi M
Chem Sci; 2023 May; 14(21):5743-5755. PubMed ID: 37265738
[TBL] [Abstract][Full Text] [Related]
20. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
